| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-PDGFD (250-350) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.05% Proclin300, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:1000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
PDGFD |
| Gene ID: |
80310 |
| Uniprot ID: |
PDGFD_HUMAN |
| Immunogen Region: |
250-350 |
| Immunogen: |
A synthetic peptide corresponding to a sequence within amino acids 250-350 of human PDGFD (NP_079484.1). |
| Immunogen Sequence: |
SYHDRKSKVDLDRLNDDAKR YSCTPRNYSVNIREELKLAN VVFFPRCLLVQRCGGNCGCG TVNWRSCTCNSGKTVKKYHE VLQFEPGHIKRRGRAKTMAL V |
| Tissue Specificity | Expressed at high levels in the heart, pancreas, adrenal gland and ovary and at low levels in placenta, liver, kidney, prostate, testis, small intestine, spleen and colon. In the kidney, expressed by the visceral epithelial cells of the glomeruli. A widespread expression is also seen in the medial smooth muscle cells of arteries and arterioles, as well as in smooth muscle cells of vasa rectae in the medullary area. Expressed in the adventitial connective tissue surrounding the suprarenal artery. In chronic obstructive nephropathy, a persistent expression is seen in glomerular visceral epithelial cells and vascular smooth muscle cells, as well as de novo expression by periglomerular interstitial cells and by some neointimal cells of atherosclerotic vessels. Expression in normal prostate is seen preferentially in the mesenchyme of the gland while expression is increased and more profuse in prostate carcinoma. Expressed in many ovarian, lung, renal and brain cancer-derived cell lines. |
| Post Translational Modifications | Activated by proteolytic cleavage. Proteolytic removal of the N-terminal CUB domain releasing the core domain is necessary for unmasking the receptor-binding epitopes of the core domain. Cleavage after Arg-247 or Arg-249 by urokinase plasminogen activator gives rise to the active form. |
| Function | Growth factor that plays an essential role in the regulation of embryonic development, cell proliferation, cell migration, survival and chemotaxis. Potent mitogen for cells of mesenchymal origin. Plays an important role in wound healing. Induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Can initiate events that lead to a mesangial proliferative glomerulonephritis, including influx of monocytes and macrophages and production of extracellular matrix. |
| Protein Name | Platelet-Derived Growth Factor DPdgf-DIris-Expressed Growth FactorSpinal Cord-Derived Growth Factor BScdgf-B Cleaved Into - Platelet-Derived Growth Factor D - Latent FormPdgfd Latent Form - Platelet-Derived Growth Factor D - Receptor-Binding FormPdgfd Receptor-Binding Form |
| Database Links | Reactome: R-HSA-186797 |
| Cellular Localisation | SecretedReleased By Platelets Upon Wounding |
| Alternative Antibody Names | Anti-Platelet-Derived Growth Factor D antibodyAnti-Pdgf-D antibodyAnti-Iris-Expressed Growth Factor antibodyAnti-Spinal Cord-Derived Growth Factor B antibodyAnti-Scdgf-B Cleaved Into - Platelet-Derived Growth Factor D - Latent Form antibodyAnti-Pdgfd Latent Form - Platelet-Derived Growth Factor D - Receptor-Binding Form antibodyAnti-Pdgfd Receptor-Binding Form antibodyAnti-PDGFD antibodyAnti-IEGF antibodyAnti-SCDGFB antibodyAnti-MSTP036 antibodyAnti-UNQ1899 antibodyAnti-PRO4345 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
